A groundbreaking study has successfully translated high-field nuclear magnetic resonance (NMR) spectroscopy-based lipoprotein ...

Bruker Corporation (NASDAQ:BRKR) stands second among the best medical technology stocks to buy according to analysts. It is a leading provider of scientific instruments and analytical solutions ...

Last month, we reported that Native Instruments was planning to expand its software ecosystem by teaming up with a handful of competitors to integrate its NKS protocol with their products. Today, the ...

The "Fluorescence Microscopy Market" report has been added to ResearchAndMarkets.com's offering.

As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...

In the past, traditional Japanese instruments helped music grace the halls of royals and accompanied theater performances. Today you can hear it on TV, at a kabuki show, or a festival. So, here are ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.